| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 2 | -34.8K | 100% | $1.83 | -$63.8K |
| Net | -2 | -34.8K | -100% | -$63.8K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Patrick J. Heron | Director | $16.2M | Jun 23, 2025 | ||
| David A. Socks | CFO & Chief Business Officer | $11.9M | Apr 28, 2022 | ||
| Astrid Borkowski | Chief Medical Officer | $3.21M | Feb 8, 2024 | ||
| Susan Silbermann | Director | $651K | Aug 19, 2022 | ||
| Sean McLoughlin | Chief Operating Officer | $21.2K | Mar 28, 2024 | ||
| Takeda Pharmaceutical Co Ltd | 10%+ Owner | $0 | Sep 17, 2025 | ||
| Jeryl L. Hilleman | Director | $0 | Sep 17, 2025 | ||
| Jaime Sepulveda | Director | $0 | Sep 17, 2025 | ||
| Shelley Chu | Director | $0 | Sep 17, 2025 | ||
| Aditya Kohli | Director | $0 | Sep 17, 2025 | ||
| Julie Gerberding | Director | $0 | Sep 17, 2025 | ||
| Gary Dubin | Director | $0 | Sep 17, 2025 | ||
| Robert Hershberg | President and CEO, Director | $0 | -$48.7K | -100% | Sep 17, 2025 |
| Frazier Life Sciences X, L.P. | 10%+ Owner | $0 | Sep 17, 2025 | ||
| Shane Maltbie | Chief Financial Officer | $0 | -$15.1K | -100% | Sep 17, 2025 |
| Nanette Cocero | Director | $0 | Sep 17, 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|